Thyrocare Technologies has announced a final dividend of Rs. 7.00 per share for the financial year 2025-26, bringing the total payout for the year to Rs. 9.33 per share. The company also disclosed significant leadership shifts, including the re-appointment of its Managing Director and the induction of new board members. Additionally, Thyrocare approved an investment of up to Rs. 5.50 crore in its subsidiary, Think Health Diagnostics, to support future growth and operations.
Financial Highlights and Dividend
Following the Board Meeting held on May 7, 2026, the company recommended a final dividend of Rs. 7.00 per equity share for the fiscal year 2025-26, pending shareholder approval. This follows an interim dividend of Rs. 7.00 per share (pre-bonus adjustment) already paid, resulting in a total annual dividend of Rs. 9.33 per share post-bonus. The final payout is scheduled to occur within 30 days of the upcoming Annual General Meeting.
Strategic Leadership Changes
The company announced several key leadership updates. Mr. Rahul Franklin Guha has been re-appointed as Chairman, Managing Director, and CEO for a further five-year term, effective May 4, 2027, through May 3, 2032. Furthermore, the Board welcomed Mr. Uday Patel Kadam and Mr. Gaurav Verma as new Non-Executive, Non-Independent Directors, effective May 8, 2026. These appointments follow the resignations of Mr. Dharmil Nirupam Sheth and Dr. Dhaval Rajesh Shah, both of whom stepped down due to other professional commitments.
Expansion of Diagnostic Capabilities
To bolster its position in the healthcare ecosystem, the Board approved an investment of up to Rs. 5.50 crore in its wholly-owned subsidiary, Think Health Diagnostics Private Limited. This capital infusion is intended to support the subsidiary’s business operations, capital expenditure, and working capital needs. Additionally, the company has initiated an amendment to its Memorandum of Association to broaden its scope of activities, allowing for a more extensive reach into healthcare, diagnostics, and allied services in India and abroad.
Governance and Auditing Updates
As part of its long-term governance strategy, the company has recommended the appointment of Price Waterhouse Chartered Accountants LLP as the new Statutory Auditors for a five-year term, covering the 26th to the 31st Annual General Meetings. Furthermore, M/s. Jitender Navneet & Co. has been appointed as the Cost Auditor for the financial year 2026-27.
Source: BSE
